bosutinib 400 MG Oral Tablet

RxCUI
1987732
RxNorm name
bosutinib 400 MG Oral Tablet
Display name
Bosutinib (Oral Pill)
Full name
bosutinib 400 MG Oral Tablet
Term type
SCD
Status
Active
Strength
400 mg
Dose form
Tab
Route
Oral Pill
Updated
2026-11-02 22:16:56

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122017
Active start
122017
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
bosutinib400 MG / 1 EACHbosutinibbosutinib

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Oral Tablet317541

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
bosutinib1307619

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRbosutinib 400 MG Oral Tablet1NAMES
RxNorm Namebosutinib 400 MG Oral Tablet1NAMES
RxNorm Synonymbosutinib 400 MG (as bosutinib monohydrate 413.6 MG) Oral Tablet1NAMES
TTYSCD1ATTRIBUTES
SPL_SET_IDcb7a8d1d-07c0-462d-960f-214d44705e761CODES
RxCUI19877321CODES
MMSL_CODE
2 linked values
2CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
75907-405-3075907-405Bosutinib BosutinibDr. Reddy's Laboratories Inc.ANDA209624

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
ANDA20962475907-405Bosutinib BosutinibANDADr. Reddy's Laboratories Inc.

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 1 matching rows.

NDC11, Source, Active table
NDC11SourceActive
75907040530rxnav_ndcsyes

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 3 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BOSULIFBOSUTINIBU.S. Pharmaceuticalsd5929f91-6496-4c0e-97e8-0bd524e157632026-05-28Warnings, Adverse reactionsExact identifier
rxcui: 1987732
BosutinibBOSUTINIBDr. Reddy's Laboratories Inc.cb7a8d1d-07c0-462d-960f-214d44705e762026-05-25Warnings, Adverse reactionsExact identifier
ndc (package): 75907-405-30
ndc (product): 75907-405
ndc11 (package): 75907040530
rxcui: 1987732
BOSULIFBOSUTINIBPfizer Laboratories Div Pfizer Incadc84ad5-a04d-4fee-9ba8-91f7abd928e32026-03-10Warnings, Adverse reactionsExact identifier
rxcui: 1987732

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 2 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
adc84ad5-a04d-4fee-9ba8-91f7abd928e3bosutinib 400 MG Oral Tablet [PSN] · bosutinib 400 MG Oral Tablet [SCD] · bosutinib 400 MG (as bosutinib monohydrate 413.6 MG) Oral Tablet [SY]332These highlights do not include all the information needed to use BOSULIF safely and effectively. See full prescribing information for BOSULIF. BOSULIF ® (bosutinib) tablets, for oral use BOSULIF ® (bosutinib) capsules, for oral use Initial U.S. Approval: 201220260310
d5929f91-6496-4c0e-97e8-0bd524e15763bosutinib 400 MG Oral Tablet [PSN] · bosutinib 400 MG Oral Tablet [SCD] · bosutinib 400 MG (as bosutinib monohydrate 413.6 MG) Oral Tablet [SY]36These highlights do not include all the information needed to use BOSULIF safely and effectively. See full prescribing information for BOSULIF. BOSULIF ® (bosutinib) tablets, for oral use BOSULIF ® (bosutinib) capsules, for oral use Initial U.S. Approval: 201220260528

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
cb7a8d1d-07c0-462d-960f-214d44705e76These highlights do not include all the information needed to use BOSUTINIB TABLETS safely and effectively. See full prescribing information for BOSUTINIB TABLETS. BOSUTINIB tablets, for oral use Initial U.S. Approval: 2012Dr. Reddy's Laboratories Inc. | MSN LABORATORIES PRIVATE LIMITED20260525

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCL01EABCR-ABL tyrosine kinase inhibitorsATC1-4bosutinib
FDASPLN0000175605Kinase InhibitorEPChas_epcbosutinib
FDASPLN0000020009Bcr-Abl Tyrosine Kinase InhibitorsMOAhas_moabosutinib
MEDRTD000814Aniline CompoundsCHEMhas_ingredientbosutinib
MEDRTD009570NitrilesCHEMhas_ingredientbosutinib
MEDRTD011804QuinolinesCHEMhas_ingredientbosutinib
MEDRTD004342Drug HypersensitivityDISEASEci_withbosutinib
MEDRTD015464Leukemia, Myelogenous, Chronic, BCR-ABL PositiveDISEASEmay_treatbosutinib
MEDRTN0000020001Tyrosine Kinase InhibitorsMOAhas_moabosutinib
MEDRTN0000175672Cellular Proliferation AlterationPEhas_pebosutinib

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH400 MG
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESANDAANDA209624
CODESSNOMEDCT1145412001
CODESVUID4037170
NAMESPrescribable Synonymbosutinib 400 MG Oral Tablet
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File